TMPRSS11A

gene
On this page

Also known as ECRG1HATL1HESP

Summary

TMPRSS11A (transmembrane serine protease 11A, HGNC:27954) is a protein-coding gene on chromosome 4q13.2, encoding Transmembrane protease serine 11A (Q6ZMR5). Probable serine protease which may play a role in cellular senescence.

Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region and plasma membrane.

Source: NCBI Gene 339967 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 69 total
  • MANE Select transcript: NM_001114387

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27954
Approved symbolTMPRSS11A
Nametransmembrane serine protease 11A
Location4q13.2
Locus typegene with protein product
StatusApproved
AliasesECRG1, HATL1, HESP
Ensembl geneENSG00000187054
Ensembl biotypeprotein_coding
OMIM611704
Entrez339967

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000334830, ENST00000508048, ENST00000513536, ENST00000714500, ENST00000714501, ENST00000714502

RefSeq mRNA: 2 — MANE Select: NM_001114387 NM_001114387, NM_182606

CCDS: CCDS3519, CCDS47065

Canonical transcript exons

ENST00000508048 — 10 exons

ExonStartEnd
ENSE000013390726794645067946571
ENSE000015241886794451967944637
ENSE000020218986796338367963493
ENSE000040241726792412867924166
ENSE000040241736790939567911503
ENSE000040241746793199367932060
ENSE000040241766791897367919232
ENSE000040241796792988067930040
ENSE000040241816791458867914730
ENSE000040241826792275567922926

Expression profiles

Bgee: expression breadth broad, 41 present calls, max score 93.41.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2420 / max 83.5621, expressed in 22 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
523210.199819
523230.02399
523220.01486
523200.00363

Top tissues by expression

106 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
esophagus mucosaUBERON:000246993.41gold quality
lower esophagus mucosaUBERON:003583488.45gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.14gold quality
vaginaUBERON:000099682.27gold quality
tonsilUBERON:000237270.90gold quality
esophagusUBERON:000104366.54gold quality
olfactory segment of nasal mucosaUBERON:000538657.80gold quality
ectocervixUBERON:001224954.22gold quality
uterine cervixUBERON:000000252.04gold quality
minor salivary glandUBERON:000183049.64gold quality
bone marrow cellCL:000209248.18gold quality
saliva-secreting glandUBERON:000104448.09gold quality
corpus callosumUBERON:000233646.88silver quality
ventricular zoneUBERON:000305344.02silver quality
urinary bladderUBERON:000125543.87gold quality
right coronary arteryUBERON:000162541.64silver quality
colonic epitheliumUBERON:000039741.40gold quality
bone marrowUBERON:000237137.88gold quality
primary visual cortexUBERON:000243637.34gold quality
ganglionic eminenceUBERON:000402337.20gold quality
granulocyteCL:000009436.83gold quality
esophagogastric junction muscularis propriaUBERON:003584136.65gold quality
cortical plateUBERON:000534336.47gold quality
lower esophagusUBERON:001347336.41gold quality
liverUBERON:000210736.38gold quality
lower esophagus muscularis layerUBERON:003583336.13gold quality
hindlimb stylopod muscleUBERON:000425235.84gold quality
cortex of kidneyUBERON:000122535.76silver quality
prostate glandUBERON:000236735.74gold quality
gall bladderUBERON:000211035.02silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.67

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

60 targeting TMPRSS11A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-150-5P99.9966.691976
HSA-MIR-428299.9975.366408
HSA-MIR-1213699.9872.815713
HSA-MIR-548N99.9871.944170
HSA-MIR-314899.9775.066478
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-302E99.9670.742669
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-651-3P99.9473.485177
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-652-5P99.9167.49505
HSA-MIR-684499.8270.692423
HSA-MIR-3913-5P99.7867.26968
HSA-MIR-4713-5P99.7867.801794
HSA-MIR-498-5P99.7669.641807
HSA-MIR-5580-3P99.7069.412052
HSA-MIR-519A-3P99.6771.671868
HSA-MIR-519B-3P99.6771.671868
HSA-MIR-519C-3P99.6771.671870
HSA-MIR-10393-5P99.6568.011368
HSA-MIR-3679-3P99.6469.881599
HSA-MIR-368599.6268.831621
HSA-MIR-885-5P99.5968.59879
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-312299.5066.33821

Literature-anchored findings (GeneRIF, showing 10)

  • findings indicate that ECRG1 may be a candidate tumor suppressor gene for esophageal cancer involved in cell-cycle control (PMID:17971341)
  • DNA polymorphisms in the coding region of ECRG1 are associated with poor outcome after surgical resection in esophageal carcinoma. (PMID:19052822)
  • no significant association between single nucleotide polymorphisms Arg/Arg, Arg/Gln and Gln/Gln and survival in oral squamous cell carcinoma (PMID:19394797)
  • Data show that ECRG4 interacts directly with ECRG1 to upregulate p21 protein expression, induce cell cycle G1 phase block and inhibit cancer cells proliferation in ESCC. (PMID:21288367)
  • A statistically significantly increased risk of ESCC was found to be associated with the ECRG1 Arg/Gln and Gln/Gln genotype. (PMID:21517269)
  • Data show that the allele types of ECRG1 were Arg/Arg (54.2%), Arg/Gln (45.8%) and Gln/Gln (0.00%), and the allele types of FGFR4 amino acid 388 were Arg/Arg (8.3%), Arg/Gly (54.2%) and Gly/Gly (37.5%). (PMID:23481570)
  • This suggests that substitution of the arginine in the conserved catalytic domain of the ECRG1 protein might reduce its catalytic capacity by impacting its 3-dimensional conformation, thereby causing the genetic susceptibility to ESCC. [review] (PMID:23548972)
  • ECRG1 Arg290Gln polymorphism significantly affects the susceptibility but not the prognosis of esophageal squamous cell carcinoma patients in low-risk north Indian population. (PMID:23869757)
  • show that TMPRSS11A, another member of the TTSP family, cleaves and activates the influenza A virus (FLUAV) HA and the Middle East respiratory syndrome coronavirus spike protein (MERS-S). (PMID:29976755)
  • Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease. (PMID:32675285)

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
danio_reriost14bENSDARG00000044655
danio_reriost14aENSDARG00000061173
danio_rerioENSDARG00000062758
danio_reriotmprss15ENSDARG00000079393
mus_musculusTmprss11aENSMUSG00000072845
rattus_norvegicusTmprss11aENSRNOG00000046764
drosophila_melanogasterSbFBGN0003319
drosophila_melanogasterCG1632FBGN0030027
drosophila_melanogasterCG10587FBGN0037039
drosophila_melanogasterCG17242FBGN0250841

Paralogs (17): PRSS22 (ENSG00000005001), PRSS21 (ENSG00000007038), TMPRSS11E (ENSG00000087128), HPN (ENSG00000105707), TMPRSS13 (ENSG00000137747), ST14 (ENSG00000149418), TMPRSS11D (ENSG00000153802), TMPRSS15 (ENSG00000154646), TMPRSS3 (ENSG00000160183), TMPRSS5 (ENSG00000166682), TMPRSS7 (ENSG00000176040), TMPRSS9 (ENSG00000178297), TMPRSS2 (ENSG00000184012), TMPRSS11B (ENSG00000185873), TMPRSS6 (ENSG00000187045), TMPRSS11F (ENSG00000198092), PRSS41 (ENSG00000215148)

Protein

Protein identifiers

Transmembrane protease serine 11AQ6ZMR5 (reviewed: Q6ZMR5)

Alternative names: Airway trypsin-like protease 1, Epidermal type-II transmembrane serine protease, Esophageal cancer-susceptibility gene 1 protein

All UniProt accessions (5): A0A0A0MR82, A0AAQ5BI39, A0AAQ5BIA6, Q6ZMR5, H0YAL9

UniProt curated annotations — full annotation on UniProt →

Function. Probable serine protease which may play a role in cellular senescence. Overexpression inhibits cell growth and induce G1 cell cycle arrest.

Subunit / interactions. May interact with ZBTB17.

Subcellular location. Membrane.

Tissue specificity. Expressed in esophagus, liver, colon and lung. Down-regulated in esophagus cancers.

Similarity. Belongs to the peptidase S1 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZMR5-22yes
Q6ZMR5-11

RefSeq proteins (2): NP_001107859, NP_872412 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000082SEA_domDomain
IPR001254Trypsin_domDomain
IPR001314Peptidase_S1AFamily
IPR009003Peptidase_S1_PAHomologous_superfamily
IPR017329Pept_S1A_HAT/DESC1Family
IPR018114TRYPSIN_HISActive_site
IPR033116TRYPSIN_SERActive_site
IPR036364SEA_dom_sfHomologous_superfamily
IPR043504

Pfam: PF00089, PF01390

Enzyme classification (BRENDA):

  • EC 3.4.21.B61 — (BRENDA: organisms, substrates, inhibitors, Km, kcat entries)

UniProt features (24 total): sequence conflict 8, disulfide bond 3, active site 3, topological domain 2, glycosylation site 2, domain 2, chain 1, splice variant 1, sequence variant 1, transmembrane region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
9P1CX-RAY DIFFRACTION2.54

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZMR5-F187.780.63

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 227 (charge relay system); 272 (charge relay system); 368 (charge relay system)

Disulfide bonds (3): 212–228, 337–353, 364–393

Glycosylation sites (2): 303, 153

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 42 (showing top): chr4q13, GOBP_PROTEIN_MATURATION, WTGAAAT_UNKNOWN, HAND1E47_01, LEIN_CHOROID_PLEXUS_MARKERS, WGGAATGY_TEF1_Q6, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, GOBP_PROTEIN_PROCESSING, BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE, ICSBP_Q6, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN, HMGA1_TARGET_GENES, MIR6867_5P, MIR7_1_3P

GO Biological Process (1): proteolysis (GO:0006508)

GO Molecular Function (4): serine-type endopeptidase activity (GO:0004252), serine-type peptidase activity (GO:0008236), peptidase activity (GO:0008233), hydrolase activity (GO:0016787)

GO Cellular Component (3): extracellular region (GO:0005576), plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
protein metabolic process1
endopeptidase activity1
serine-type peptidase activity1
peptidase activity1
serine hydrolase activity1
hydrolase activity1
catalytic activity, acting on a protein1
catalytic activity1
membrane1
cell periphery1

Protein interactions and networks

STRING

680 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMPRSS11AFURINP09958613
TMPRSS11ACTSLP07711591
TMPRSS11AACE2Q9BYF1577
TMPRSS11ACDKN1AP38936497
TMPRSS11AANPEPP15144462
TMPRSS11ATOP3BO95985455
TMPRSS11ADPP4P27487419
TMPRSS11AOR5AK2Q8NH90411
TMPRSS11AECRG4Q9H1Z8399
TMPRSS11AAP2A2O94973396
TMPRSS11AAP2M1P20172382
TMPRSS11ASPINT2O43291381
TMPRSS11ARAB14P35287379
TMPRSS11ACTSBP07858375
TMPRSS11ASPINK7P58062373

IntAct

5 interactions, top by confidence:

ABTypeScore
TMPRSS11ASpsi-mi:“MI:0570”(protein cleavage)0.440
MYCpsi-mi:“MI:0914”(association)0.350
TMPRSS11APAK4psi-mi:“MI:0914”(association)0.350
TMPRSS11APCDH1psi-mi:“MI:0914”(association)0.350

BioGRID (23): SERPINB6 (Affinity Capture-MS), PAK4 (Affinity Capture-MS), ACADL (Affinity Capture-MS), RSPRY1 (Affinity Capture-MS), PSG3 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMPRSS11A (Biochemical Activity), ACADL (Affinity Capture-MS), PSG3 (Affinity Capture-MS), RSPRY1 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), PAK4 (Affinity Capture-MS), ACE2 (Biochemical Activity), RSPRY1 (Affinity Capture-MS), PAK4 (Affinity Capture-MS)

ESM2 similar proteins: A0A126GUP6, A0A1S4H5M5, A0A1S4H5S2, A6MFK7, B5U2W0, F5HKX0, O60235, O88947, O97366, P00740, P05049, P13582, P15120, P15638, P16292, P16293, P16294, P19540, P21902, P25155, P29598, P49150, P81428, P82807, P83370, P98121, Q14C59, Q27081, Q27083, Q2VG86, Q3UQ41, Q49QW1, Q4QXT9, Q63207, Q6ZMR5, Q7PEV7, Q7QBP4, Q804X6, Q8I6K0, Q8MZM7

Diamond homologs: A0A1S4GMJ4, A6NIE9, A8JUP7, G3V801, O08762, O42207, O60235, P00741, P00745, P00762, P00765, P03951, P05049, P07477, P07478, P0CW18, P15120, P16292, P16295, P19799, P29786, P29787, P35030, P35039, P69525, P79953, Q14B25, Q14BX2, Q14C59, Q1JRP2, Q27081, Q28278, Q28315, Q28412, Q29463, Q2KJ63, Q2VG86, Q5G265, Q5U405, Q6BEA2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

69 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance60
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1954 predictions. Top by Δscore:

VariantEffectΔscore
4:67914581:AACTT:Adonor_loss1.0000
4:67914582:ACTTA:Adonor_loss1.0000
4:67914583:CTT:Cdonor_loss1.0000
4:67914584:TTA:Tdonor_loss1.0000
4:67914585:T:TGdonor_loss1.0000
4:67914586:A:ACdonor_gain1.0000
4:67914586:AC:Adonor_gain1.0000
4:67914586:ACCCT:Adonor_loss1.0000
4:67914587:C:CAdonor_loss1.0000
4:67914587:C:CCdonor_gain1.0000
4:67914587:CC:Cdonor_gain1.0000
4:67914587:CCCTG:Cdonor_gain1.0000
4:67914726:TTCCC:Tacceptor_gain1.0000
4:67914728:CCC:Cacceptor_gain1.0000
4:67914728:CCCCT:Cacceptor_gain1.0000
4:67914729:CC:Cacceptor_gain1.0000
4:67914729:CCCT:Cacceptor_gain1.0000
4:67914730:CC:Cacceptor_gain1.0000
4:67914731:C:CCacceptor_gain1.0000
4:67914731:C:Tacceptor_gain1.0000
4:67914731:CTTA:Cacceptor_loss1.0000
4:67914732:T:Cacceptor_gain1.0000
4:67922748:AACTT:Adonor_loss1.0000
4:67922749:ACTT:Adonor_loss1.0000
4:67922751:TTA:Tdonor_loss1.0000
4:67922752:TA:Tdonor_loss1.0000
4:67922753:A:ACdonor_gain1.0000
4:67922753:ACTT:Adonor_gain1.0000
4:67922754:C:CAdonor_gain1.0000
4:67922754:C:Tdonor_loss1.0000

AlphaMissense

2742 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:67914625:C:GC356S0.999
4:67914626:A:TC356S0.999
4:67914673:C:GC340S0.998
4:67914674:A:TC340S0.998
4:67918992:A:CF314L0.998
4:67918992:A:TF314L0.998
4:67918994:A:GF314L0.998
4:67911366:C:AW414C0.997
4:67911366:C:GW414C0.997
4:67911421:C:GC396S0.997
4:67911422:A:TC396S0.997
4:67911432:C:AW392C0.997
4:67911432:C:GW392C0.997
4:67914624:A:CC356W0.997
4:67914625:C:TC356Y0.997
4:67919105:C:GA277P0.997
4:67922763:G:CC231W0.997
4:67922812:C:GC215S0.997
4:67922813:A:TC215S0.997
4:67922849:A:GW203R0.997
4:67922849:A:TW203R0.997
4:67911435:G:CS391R0.996
4:67911435:G:TS391R0.996
4:67911437:T:GS391R0.996
4:67911445:C:TG388E0.996
4:67911493:C:AG372V0.996
4:67911494:C:AG372W0.996
4:67914592:C:GC367S0.996
4:67914593:A:TC367S0.996
4:67914626:A:GC356R0.996

dbSNP variants (sampled 300 via entrez): RS1000001551 (4:67917155 C>G), RS1000018024 (4:67938727 G>A), RS1000122246 (4:67929187 C>T), RS1000159763 (4:67913942 T>C), RS10001655 (4:67942728 G>C,T), RS10001742 (4:67942829 G>A,C), RS1000266738 (4:67954854 A>G), RS1000321624 (4:67935018 GA>G,GAA), RS1000435154 (4:67919911 G>A), RS1000442077 (4:67928906 G>C), RS1000447674 (4:67960885 A>G), RS1000471511 (4:67928594 C>T), RS1000511160 (4:67956016 T>G), RS1000607364 (4:67956399 T>G), RS1000613659 (4:67915847 C>T)

Disease associations

OMIM: gene MIM:611704 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006921_13Regular attendance at a pub or social club7.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0009592social interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases methylation, decreases expression2
bisphenol Aincreases methylation1
glycidyl methacrylateincreases expression1
sodium arseniteincreases expression1
monomethylarsonous acidincreases expression1
Allergensincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.